NCT01133015

Brief Summary

This study will evaluate the relationship of Fractional Flow Reserve (FFR) and Minimal Lumen Area (MLA) by IntraVascular UltraSound (IVUS) by comparing the results of the both tests which is done as a part of the cardiac catheterization.

Trial Health

43
At Risk

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Trial has exceeded expected completion date
Enrollment
191

participants targeted

Target at P50-P75 for phase_4

Timeline
Completed

Started Mar 2009

Typical duration for phase_4

Geographic Reach
1 country

1 active site

Status
unknown

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Start

First participant enrolled

March 1, 2009

Completed
1.2 years until next milestone

First Submitted

Initial submission to the registry

May 24, 2010

Completed
4 days until next milestone

First Posted

Study publicly available on registry

May 28, 2010

Completed
1.4 years until next milestone

Primary Completion

Last participant's last visit for primary outcome

November 1, 2011

Completed
Same day until next milestone

Study Completion

Last participant's last visit for all outcomes

November 1, 2011

Completed
Last Updated

July 21, 2011

Status Verified

July 1, 2011

Enrollment Period

2.7 years

First QC Date

May 24, 2010

Last Update Submit

July 20, 2011

Conditions

Keywords

FFRIVUSMLA

Outcome Measures

Primary Outcomes (1)

  • lumen area

    lumen area cut-off that can predict the functional significance of a lesion

    1 day

Secondary Outcomes (2)

  • angiographic stenosis, % plaque area

    1 day

  • CT measurement

    1 day

Study Arms (1)

Intermediate lesion

EXPERIMENTAL

Intermediate lesion will be evaluated by both IVUS and FFR

Device: Fractional flow reserveDevice: IVUS

Interventions

Fractional flow reserve measured by pressure wire

Also known as: RADI pressure wire
Intermediate lesion
IVUSDEVICE

intravascular ultrasound

Also known as: Volcano IVUS, boston scientific
Intermediate lesion

Eligibility Criteria

Age21 Years - 85 Years
Sexall
Healthy VolunteersNo
Age GroupsAdult (18-64), Older Adult (65+)

You may qualify if:

  • Age 21-85
  • Presence of at least one obstructive coronary artery stenosis as defined by:
  • Previous catheterization or CT angiogram with any lesion 70% or greater
  • Previous positive functional stress test (this does not include CTA alone)
  • Ability and Willingness to provide informed consent
  • Ability and Willingness to perform required follow up procedures

You may not qualify if:

  • History of coronary artery bypass graft surgery
  • Previously revascularized lesion
  • Creatinine\>1.6 mg/dL or GFR\<30 pre-procedure per institutional standards
  • Known Pregnancy
  • Inability to perform CTA
  • Arrhythmia precluding diagnostic CT examination
  • Contrast agent allergy that cannot be adequately premedicated
  • Severe PVD precluding cardiac catheterization
  • Patient not a candidate for IVUS and FFR
  • Inability or unwillingness to provide informed consent
  • Inability or unwillingness to perform required follow up procedures

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Seoul national university hospital

Seoul, 110-744, South Korea

RECRUITING

Related Publications (1)

  • Koo BK, Yang HM, Doh JH, Choe H, Lee SY, Yoon CH, Cho YK, Nam CW, Hur SH, Lim HS, Yoon MH, Park KW, Na SH, Youn TJ, Chung WY, Ma S, Park SK, Kim HS, Tahk SJ. Optimal intravascular ultrasound criteria and their accuracy for defining the functional significance of intermediate coronary stenoses of different locations. JACC Cardiovasc Interv. 2011 Jul;4(7):803-11. doi: 10.1016/j.jcin.2011.03.013.

MeSH Terms

Conditions

Coronary Stenosis

Condition Hierarchy (Ancestors)

Coronary DiseaseMyocardial IschemiaHeart DiseasesCardiovascular DiseasesVascular Diseases

Study Officials

  • Bon-kwon Koo, MD/PhD

    Seoul National University Hospital

    PRINCIPAL INVESTIGATOR

Central Study Contacts

Bon-kwon Koo, MD/PhD

CONTACT

Study Design

Study Type
interventional
Phase
phase 4
Allocation
NA
Masking
NONE
Purpose
DIAGNOSTIC
Intervention Model
SINGLE GROUP
Sponsor Type
OTHER

Study Record Dates

First Submitted

May 24, 2010

First Posted

May 28, 2010

Study Start

March 1, 2009

Primary Completion

November 1, 2011

Study Completion

November 1, 2011

Last Updated

July 21, 2011

Record last verified: 2011-07

Locations